U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT06810219) titled 'Augmented Reality BCI Longitudinal Study for Persons with Late Stage ALS' on Jan. 22.
Brief Summary: The goal of this study is refine the usability of a BCI based communication platform.
The study will take place in the greater Los Angeles area and will enroll up to 10 participants with late stage ALS. Each subject will receive a Cognixion Axon-R augmented reality brain computer interface and associated communication software. The study duration is 3 months for each participant.
The key questions that will be addressed in this study are:
1. How quickly can participants learn and gain confidence with a pure BCI interface.
2. How e...